Lorient Capital has closed its third fund, Lorient Healthcare Fund III, with $500 million in total commitments, surpassing its initial target of $350 million.
Why it matters: The successful fundraise highlights the continued interest in healthcare investments, despite a shift in the landscape for private equity and venture capital firms.
The details:
- Lorient Capital, based in Detroit, focuses on founder-led companies in the middle market, targeting sectors such as post-acute care, behavioral health, provider enablement, and tech-enabled services.
- The firm favors control-oriented investments where it can apply its operational expertise to drive growth and improve performance.
- Lorient’s proprietary technology platform, Morpheus, integrates clinical, operational, and financial data to support management teams in decision-making and performance improvement.
Co-Managing Partners David Berman and Jordan Broome emphasized that the new fund aims to support healthcare businesses focused on improving clinical outcomes, workforce efficiency, and access to care.
Track record:
- Since its inception, Lorient has completed 20 platform investments and over 75 add-on acquisitions, achieving nine exits to date.
- Under Lorient’s nearly five-year stewardship, portfolio company Behavior Frontiers expanded its active client base from approximately 900 to 2,850 and grew its workforce from 1,300 to over 3,300 employees.
Team expansion: Lorient has strengthened its team with the addition of Stephanie DeGennaro as general counsel and John Cotcher as vice president of compliance and HR operations.
Looking ahead: By leveraging their strategic approach and innovative platforms, Lorient Capital is positioning itself to make a significant impact on the healthcare industry.